NEW YORK, April 25, 2018 -- According to the new market research report published by P&S Market Research, global scar treatment market size is expected to reach $34.1 billion by 2023, growing at a CAGR of 10.0% between 2017-2023. Rising appearance consciousness among consumers, increasing prevalence of skin diseases, increasing awareness among people for scar treatment, technological advancements in scar treatment products etc. are some of the major factors driving the growth of the market.
Request to get the sample pages: https://www.psmarketresearch.com/market-analysis/scar-treatment-market/report-sample
Based on type of scars, the global scar treatment market is segmented into post-surgical scar, acne scar, keloid and hypertrophic scar, contracture scar and stretch mark. The post-surgical scar is expected to have the largest market by 2023. The keloid and hypertrophic scar is expected to be the fastest growing segment between 2017-2023.
The online availability of scar treatment products, such as scar treating creams, sprays, oils and gels, have led to increased accessibility of these products around the world. Additionally, buying products online is time saving, which offers discounted prices and is more convenient, allowing the customers to purchase the products, irrespective of geographical barriers. Some of the scar treatment products available online include Bio-oil, Revitol Scar Cream, Mederma, CELSUS Scar Treatment Cream, CICA-CARE Silicone Gel Sheets, and Scar Zone Burn Gel. Increasing accessibility of scar treatment products further fuel the growth of the scar treatment market.
Browse Full Report with Detailed TOC on “Scar Treatment Market”at: https://www.psmarketresearch.com/market-analysis/scar-treatment-market
The invasive and non-invasive treatments for treating scars have various side effects. For instance, laser treatment for treating scars can at times lead to various side effects, such as itching, post-operative pain, blister formation, redness, bruise formation, swelling, and breakouts. These side effects may last from few hours to few weeks, depending upon the skin type of an individual. Additionally, the non-invasive treatments, such as creams, gels, sprays and oils can at times cause stinging, itching, redness, burning sensation, and skin discoloration. These side effects act as a major key barrier in the growth of the scar treatment market, globally.
Some of the key players in the global scar treatment market are Syneron Medical Ltd., Smith & Nephew Plc, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Mölnlycke Health Care AB, Merz GMBH & Co KGAA, Beijing Toplaser Technology Company Ltd., Pacific World Corporation, Valeant Pharmaceuticals International Inc., Sonoma Pharmaceuticals Inc., Avita Medical Ltd. Enaltus LLC, Scarguard Labs LLC, CCA Industries Inc., Hologic Inc. and Quantum Health.
More Published Reports by P&S Market Research
Single-Cell Analysis Market
Among the different type of single-cell analysis consumable products, the reagents segment is expected to witness the fastest growth during the forecast period. Among the different type of technique, the next-Generation Sequencing (NGS) segment is expected to witness the fastest growth during the forecast period.
https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market
Adhesion Barrier Market
Geographically, North America has been globally the largest market of adhesion barriers, owing to the growing cases of abdominal problems, neurological diseases and cardiovascular diseases in the region. However, the adhesion barrier market is expected to witness fastest growth in Asia-Pacific, with a CAGR of 8.8% during the period 2016– 2022.
https://www.psmarketresearch.com/market-analysis/adhesion-barrier-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research-based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook


AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 



